t-butylbenzoyl biotin-NHS ester
t-butylbenzoyl biotin-NHS ester - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.ON-783
-
SMILESO=C(CCCC[C@H]1C(NC(N2C(C3=CC=C(C(C)(C)C)C=C3)=O)=O)C2CS1)ON4C(CCC4=O)=O
-
Molecular FormulaC25H31N3O6S
-
Molecular Weight501.60
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityUPLC≥96%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.ON-783
-
SMILESO=C(CCCC[C@H]1C(NC(N2C(C3=CC=C(C(C)(C)C)C=C3)=O)=O)C2CS1)ON4C(CCC4=O)=O
-
Molecular FormulaC25H31N3O6S
-
Molecular Weight501.60
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityUPLC≥96%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
